Monthly Archives: May 2020
RBC Capital Keeps Their Hold Rating on Laurentian Bank (LRCDF)
Analysts Offer Insights on Healthcare Companies: Evofem Biosciences (NASDAQ: EVFM) and Argenx Se (NASDAQ: ARGX)
Paragon ID SA (PAGDF) Gets a Hold Rating from Kepler Capital
Kepler Capital Sticks to Their Buy Rating for DO & CO Aktiengesellschaft (DOCOF)
Allogene Therapeutics (ALLO) Receives a Buy from Oppenheimer
Aegis Capital Reaffirms Their Buy Rating on SCYNEXIS (SCYX)
In a report issued on April 23, Nathan Weinstein from Aegis Capital reiterated a Buy rating on SCYNEXIS (NASDAQ: SCYX), with a price target of $4.50. The company’s shares closed last Friday at $0.75. Currently, the analyst consensus on SCYNEXIS